US Patent 7629328 Nucleoside derivatives for treating hepatitis C virus infection

Patent 7629328 was granted and assigned to Smithkline Beecham Limited on December, 2009 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

December 8, 2009

Patent Application Number

12206581

Date Filed

September 8, 2008

Patent Citations Received

Patent Primary Examiner

Patent abstract

Disclosed are methods for treating hepatitis C viral infections using deaza-purine compounds of Formula I:

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7629328 Nucleoside derivatives for treating hepatitis C virus infection

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.